EUVIMEDEUVIMED entdecken
Open Access

Assessment of T2-weighted Image Quality at Prostate MRI in Patients with and Those without Intramuscular Injection of Glucagon

Karthik M Sundaram iD, Jarrett Rosenberg, Ali B Syed iD, Stephanie T Chang, Andreas M Loening iD

Radiology: Imaging Cancer · 01.05.2023 · 5 (3)

DOI: 10.1148/rycan.220070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology: Imaging Cancer, erschienen am 01.05.2023. Verfasst von Karthik M Sundaram und 4 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology, Perelman School of Medicine, The University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104-4283 (K.M.S.); …. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Hyperplasia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess whether administration of intramuscular (IM) glucagon improves T2-weighted image quality at multiparametric MRI (mpMRI) of the prostate. Materials and Methods In this Health Insurance Portability and Accountability Act-compliant single-center study, the authors retrospectively analyzed radiology reports from 3960 mpMRI examinations (2495 after exclusions) performed between September 2013 and September 2019 and performed outcome comparisons and semiquantitative image assessment of axial T2-weighted images from 120 consecutive mpMRI examinations performed between May 2015 and February 2016. Three experienced radiologists blinded to administration of IM glucagon assessed images using a five-point Likert scale (5 = no motion or blur) for overall image quality, anatomic delineation (prostate capsule, rectum, and lymph nodes), and identification of benign prostatic hyperplasia nodules. Wilcoxon rank sum and χ2 tests were used to assess quantitative parameters.

Results

The number of mpMRI radiology reports (599 examinations performed with glucagon; 1896, without glucagon) mentioning blur or motion were similar between groups (P = .82). Regression analysis of semiquantitative image quality assessments of T2-weighted images from mpMRI examinations (60 performed with glucagon; 60, without glucagon) demonstrated that images with glucagon were more likely to receive higher scores (4 or 5 rating) than those without glucagon only when the rectum (P = .001) and lymph nodes (P = .01) were evaluated, not when the prostatic capsule, benign prostatic hyperplasia nodules, or overall image quality was evaluated. No evidence of differences was found in identified Prostate Imaging Reporting and Data System (PI-RADS) lesions or targeted-biopsy Gleason scores.

Conclusion

Administration of IM glucagon did not improve T2-weighted image quality in prostate MRI examinations and showed similar PI-RADS scores and biopsy yields compared with examinations without glucagon. Keywords: MRI, Genital/Reproductive, Urinary, Prostate, Oncology, Observer Performance © RSNA, 2023 Online supplemental material is available for this article. See also commentary by Eberhardt in this issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatic HyperplasiaUnited StatesMaleHumansProstateMagnetic Resonance ImagingGlucagonInjections, IntramuscularRetrospective Studies

Stichwörter der Autor:innen

Genital/ReproductiveMRIObserver PerformanceOncologyProstateUrinary

Substanzen

Glucagon

Autor:innen und Institutionen

  • From the Department of Radiology, Perelman School of Medicine, The University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104-4283 (K.M.S.); Department of Radiology, Stanford University School of Medicine, Stanf…

ORCID-Profile: Karthik M Sundaram, Ali B Syed, Andreas M Loening

Zitieren

APA

Sundaram, K. M., Rosenberg, J., Syed, A. B., Chang, S. T., & Loening, A. M. (2023). Assessment of T2-weighted Image Quality at Prostate MRI in Patients with and Those without Intramuscular Injection of Glucagon. Radiology: Imaging Cancer, 5(3). https://doi.org/10.1148/rycan.220070

Vancouver

Sundaram KM, Rosenberg J, Syed AB, Chang ST, Loening AM. Assessment of T2-weighted Image Quality at Prostate MRI in Patients with and Those without Intramuscular Injection of Glucagon. Radiology: Imaging Cancer. 2023;5(3). doi:10.1148/rycan.220070

BibTeX
@article{Sundaram2023,
  author = {Sundaram, Karthik M and Rosenberg, Jarrett and Syed, Ali B and Chang, Stephanie T and Loening, Andreas M},
  title = {Assessment of T2-weighted Image Quality at Prostate MRI in Patients with and Those without Intramuscular Injection of Glucagon},
  journal = {Radiology: Imaging Cancer},
  year = {2023},
  volume = {5},
  number = {3},
  doi = {10.1148/rycan.220070}
}
Kostenlos starten →